‘The world has never had to vaccinate the entire population’
The likelihood of developing a vaccine by January for SARS-CoV-2, the coronavirus that causes COVID-19, is high, but complex manufacturing processes could hinder efforts to immunize every person on the planet in a short time, Christophe Weber, president and chief executive of Takeda Pharmaceuticals, told Joseph E. Aoun, president of Northeastern.
